We used our optimized kinesin-1-dependent microtubule gliding motility assay to test whether ALS-associated FUS variants directly affect kinesin-1-driven transport e.g., by acting as a road block like tau. This evidence concerns the gene MAPT and amyotrophic lateral sclerosis.